BioLineRx

IPO

Driving innovative therapeutics across the finish line.

Tel Aviv, Israel · Founded 2003 · $9.0M raised

Headquarters
Tel Aviv
Employees
51–200
Founded
2003
Business Model
B2B
Total Funding
$9.0M
Last Round
$9.0M Series BSep 2005
Rounds
2

About

BioLineRx (NASDAQ/TASE: BLRX) is a clinical-stage biopharmaceutical company headquartered in Tel Aviv, Israel, focused on developing life-changing therapies for oncology and rare diseases. Founded in 2003 by leaders in the Israeli life sciences industry — including Teva Pharmaceuticals, Giza, Pitango, and Hadasit — the company leverages full-spectrum drug development expertise to advance novel therapeutics from bench through clinical trials to regulatory approval. Its lead programs target glioblastoma (GLIX1) and hematologic malignancies via its approved motixafortide asset.

Summary

BioLineRx is a Biotech company based in Tel Aviv, Israel, founded in 2003. It has raised $9.0M in total across 2 rounds, most recently a $9.0M Series B round in Sep 2005. Investors include Giza Venture Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOFeb 2007
$50.0M

Sign up to see all 3 rounds

Series B through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BioLineRx on Indexed.vc
<a href="https://indexed.vc/companies/biolinerx"><img src="https://indexed.vc/api/badge/company/biolinerx" alt="BioLineRx on Indexed.vc" width="260" height="76" /></a>